Large international group studied polymorphisms of mismatch repair MLH1 gene in subsequent AML and breast cancer in both childhood and adult Hodgkin’s lymphoma survivors treated by methylating agents. This evidence concerns the gene MLH1 and acute myeloid leukemia.